Plasma ofCS‐modified CD44 predicts the survival of patients with lung cancer.

MLA

Wu, Zi‐Yi, et al. “Plasma OfCS‐modified CD44 Predicts the Survival of Patients with Lung Cancer.” Cancer Science, vol. 115, no. 11, Nov. 2024, pp. 3776–87. EBSCOhost, https://doi.org/10.1111/cas.16319.

APA

Wu, Z., Yang, D., He, Y., Wang, T., Zhou, T., Li, X., Zhang, P., Xue, W., Zhang, J., Mu, J., & Jia, W. (2024). Plasma ofCS‐modified CD44 predicts the survival of patients with lung cancer. Cancer Science, 115(11), 3776–3787. https://doi.org/10.1111/cas.16319

Chicago

Wu, Zi‐Yi, Da‐Wei Yang, Yong‐Qiao He, Tong‐Min Wang, Ting Zhou, Xi‐Zhao Li, Pei‐Fen Zhang, et al. 2024. “Plasma OfCS‐modified CD44 Predicts the Survival of Patients with Lung Cancer.” Cancer Science 115 (11): 3776–87. doi:10.1111/cas.16319.